Highlights

Share

Program Content

Activities

  • Preview: AIDS 2022
    My Take on the Most Outstanding Presentations at AIDS 2022
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 13, 2022

    Expires: July 12, 2023

  • Slides: AIDS 2022
    Key HIV Studies Influencing My Practice Following AIDS 2022
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 17, 2022

    Expires: August 16, 2023

  • Video Recap: Wohl
    Key HIV Studies Influencing My Practice Following AIDS 2022—Dr. David Wohl
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 19, 2022

    Expires: August 18, 2023

  • Review: AIDS 2022
    HIV Prevention and Treatment Data From AIDS 2022
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 23, 2022

    Expires: August 22, 2023

  • Video Recap: Orkin
    Key HIV Studies Influencing My Practice Following AIDS 2022—Dr. Chloe Orkin
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 20, 2022

    Expires: September 19, 2023

  • Audio Recap: AIDS 2022
    Key HIV Studies Influencing My Practice Following AIDS 2022—Audio Redcap
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 04, 2022

    Expires: October 03, 2023

Activities

HPTN 083: Results in TGW
HPTN 083: Safety, Efficacy, and Gender-Affirming Hormonal Therapy Interactions With Long-Acting Injectable CAB for HIV PrEP in Transgender Women
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 01, 2022

Expires: July 31, 2023

NAMSAL Wk 192 Results
NAMSAL: Wk 192 Results of Dolutegravir-Based vs Low-Dose Efavirenz-Based Regimens as First-line ART in Cameroon
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 02, 2022

Expires: August 01, 2023

SIMPL’HIV Wk 144
SIMPL’HIV Wk 144 Results: Dolutegravir + Emtricitabine vs Standard Combination ART for Maintenance of Virologic Suppression
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 02, 2022

Expires: August 01, 2023

ALLIANCE Study Results
ALLIANCE: Phase III Randomized Controlled Trial of BIC/FTC/TAF vs DTG + FTC/TDF in Treatment-Naive Adults With HIV/HBV Coinfection
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 03, 2022

Expires: August 02, 2023

HPTN 084: CAB in Cisgender Women
HPTN 084 Update: Long-Acting Injectable CAB vs Daily Oral TDF/FTC for HIV PrEP in Cisgender Women
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 03, 2022

Expires: August 02, 2023

DoxyPEP: Doxycycline STI PEP
DoxyPEP: Prevention of STIs With Doxycycline PEP Among MSM and TGW With HIV or Receiving PrEP
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 04, 2022

Expires: August 03, 2023

TB-PRACTECAL
TB-PRACTECAL: Efficacy and Safety of Three 24-Wk Oral Regimens for Pulmonary Rifampicin-Resistant TB in Persons With HIV
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 04, 2022

Expires: August 03, 2023

ANDES
ANDES: Generic Fixed-Dose DRV/RTV in Combination With 3TC vs 3TC/TDF for Initial HIV Treatment
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 05, 2022

Expires: August 04, 2023

6-Mo PrEP + HIVST
Effect of 6-Mo PrEP Dispensing Plus HIV Self-Testing on 12-Mo PrEP Continuation
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 05, 2022

Expires: August 04, 2023

VRC01 in Infants
IMPAACT 2008: Broadly Neutralizing Antibody VRC01 Plus ART in Infants With HIV
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 05, 2022

Expires: August 04, 2023

Faculty

cover img faculity

Daniel R. Kuritzkes, MD

Director of AIDS Research
Brigham & Womens Hospital
Professor of Medicine
Harvard Medical School
Partners AIDS Research Center
Boston, Massachusetts

cover img faculity

Sharon R. Lewin, AO, FRACP, PhD, FAHMS

Director
Doherty Institute
Melbourne Laureate Professor and Head
Department of Infectious Diseases
The University of Melbourne
Consultant Physician
Victorian Infectious Diseases Service
Royal Melbourne Hospital
Consultant Physician and Adjunct Professor Department of Infectious Diseases
Alfred Hospital and Monash University
Melbourne, Australia

cover img faculity

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Faculty of Medicine and Dentistry
Queen Mary University of London
London, United Kingdom

cover img faculity

Babafemi Taiwo, MBBS

Assistant Professor
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

cover img faculity

David A. Wohl, MD

Associate Professor of Medicine
School of Medicine
Site Leader, AIDS Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Director, North Carolina AIDS Training and Education Center
Chapel Hill, North Carolina
Co-Director for HIV Services
North Carolina Department of Correction
Raleigh, North Carolina

Provided by

ProCE Banner

Supporters

Gilead Sciences, Inc.

ViiV Healthcare

Partners

IAS 2021

ProCE Banner